A beverage containment, carbonation and serving system and method whereby the system is limited dimensionally to be placed and used inside of and fit within a standard shelving space of a conventional refrigerator. The beverage containment, carbonation and serving system and method comprises a horizontally positioned vessel, a vessel base, gas inlet and liquid outlet ports, a liquid dip tube extending from the outlet port of the vessel to the intersecting point of the vessel bottom and the opposite vessel end, an integral faucet with a vertically low-profile activation handle and an interlocking removable drip tray at one end of the vessel for liquid serving purposes.

A beverage containment, carbonation and serving system and method whereby the system is limited dimensionally to be placed and used inside of and fit within a standard shelving space of a conventional refrigerator. The beverage containment, carbonation and serving system and method comprises a horizontally positioned vessel, a vessel base, gas inlet and liquid outlet ports, a liquid dip tube extending from the outlet port of the vessel to the intersecting point of the vessel bottom and the opposite vessel end, an integral faucet with a vertically low-profile activation handle and an interlocking removable drip tray at one end of the vessel for liquid serving purposes.

Provided are a beverage, food, and a food flavor composition which are characterized by containing 3,7-dimethyl-2-methylene-6-octen-1-ol or by having 3,7-dimethyl-2-methylene-6-octen-1-ol added thereto.

In various embodiments a compound comprising the enantiomerically enriched S-isomer S-BHB-S-1,3-butanediol is provided along with methods of use thereof.

The present invention provides compositions and methods for the modulation of G protein-coupled receptors (GPCRs).

A colorless and clear beverage containing a flavoring is provided that masks an unpleasant taste or smell due to the deterioration of the flavoring and to which body is imparted. Whey protein is incorporated in the flavoring containing colorless and clear beverage.

A colorless and clear beverage containing a flavoring is provided that masks an unpleasant taste or smell due to the deterioration of the flavoring and to which body is imparted. Whey protein is incorporated in the flavoring containing colorless and clear beverage.

A hydrocarbon oil intended to be used as a drug including a content by weight of isoparaffins ranging from 90 to 100%, a content by weight of normal paraffins ranging from 0 to 10% and having a content of carbon of biological origin greater than or equal to 90% relative to the total weight of the hydrocarbon oil.

Ketogenic compositions including a non-racemic mixture of beta-hydroxybutyrate (BHB) enriched with the R-enantiomer are formulated to increase ketone body level in a subject. The non-racemic mixture of BHB is enriched with the R-enantiomer to elevate ketone bodies and increase the rate at which ketosis is achieved yet contains an amount of the S-enantiomer sufficient to provide alternative benefits as discussed herein. In some aspects a composition for increasing ketone body level in a subject contains a dietetically or pharmaceutically acceptable carrier and a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate, wherein the non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate contains from about 55% to 98% by enantiomeric equivalents of the R-beta-hydroxybutyrate and from about 45% to about 2% by enantiomeric equivalents of S-beta-hydroxybutyrate enantiomer.

Ketogenic compositions including a non-racemic mixture of beta-hydroxybutyrate (BHB) enriched with the R-enantiomer are formulated to increase ketone body level in a subject. The non-racemic mixture of BHB is enriched with the R-enantiomer to elevate ketone bodies and increase the rate at which ketosis is achieved yet contains an amount of the S-enantiomer sufficient to provide alternative benefits as discussed herein. In some aspects a composition for increasing ketone body level in a subject contains a dietetically or pharmaceutically acceptable carrier and a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate, wherein the non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate contains from about 55% to 98% by enantiomeric equivalents of the R-beta-hydroxybutyrate and from about 45% to about 2% by enantiomeric equivalents of S-beta-hydroxybutyrate enantiomer.